Key result
A review of existing randomized controlled trials and other data supports the case for tight glycaemic control in patients with acute myocardial infarction.
Why the study?
Does tight glycaemic control improve outcomes in patients with acute myocardial infarction?
Does tight glycaemic control improve outcomes in patients with acute myocardial infarction?
This review examines available trial data to support the case for tight glycaemic control in the immediate aftermath of acute myocardial infarction.
Supports tight glycaemic control in acute MI but should not yet change practice; leaves open need for definitive RCTs.
The need for tight glycaemic control in the immediate aftermath of myocardial infarction is controversial. Trials of glucose-insulin-potassium (GIK) therapy, given without regard to glucose levels, have only confused the issue. Despite considerable clinical interest, only three randomized controlled trials have, as their primary goal, aimed to determine whether better glycaemic control improves the outcomes of myocardial infarction. This review examines the results of these trials and other data to support the case for tight glycaemic control in patients with myocardial infarction.
No takes yet. Share an insight, caveat, or question.
N. Wah Cheung (2008) conducted a review in acute myocardial infarction. tight glycaemic control was evaluated. A review of existing randomized controlled trials and other data supports the case for tight glycaemic control in patients with acute myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: